Gabather AB (publ) (STO:GABA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0430
+0.0026 (6.44%)
Apr 24, 2026, 5:29 PM CET
Market Cap19.86M +110.2%
Revenue (ttm)n/a
Net Income-4.65M
EPS-0.02
Shares Out491.63M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,476,437
Average Volume6,557,584
Open0.0402
Previous Close0.0404
Day's Range0.0390 - 0.0478
52-Week Range0.0230 - 0.1300
Beta-0.65
RSI53.20
Earnings DateMay 29, 2026

About Gabather AB

Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases. The company offers drugs primarily in the areas of anti-psychotics, anti-depressants and anxiolytics, and analgesics, as well as cognition-enhancing treatments, including Alzheimer’s disease. It focuses on developing GT-002, a pro-cognitive drug candidate for the treatment of Alzheimer’s disease, schizophrenia, and major depressive disorders. The company was incorporated in 2014 and is based in Södertälje, Sweden. [Read more]

Sector Healthcare
Founded 2014
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol GABA
Full Company Profile

Financial Performance

Financial Statements